... of adult and pediatric patients two years of age and older with Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) who have received at least one prior therapy.
A study reveals that individuals with the HLA-E*01.01 gene variant face a significantly higher risk of developing multiple sclerosis (MS) only if ... .